A Study to Evaluate the Safety and Immunogenicity of an A/California/7/2009 (H1N1)V-like Vaccine GSK2340274A or GSK2340273A Co-administered With Trivalent Inactivated Seasonal Influenza Vaccine in Adults 19 to 40 Years of Age
Phase of Trial: Phase II
Latest Information Update: 08 Aug 2018
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary) ; Influenza virus vaccine
- Indications Influenza A virus H1N1 subtype; Influenza virus infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 21 Dec 2011 Actual end date changed from Dec 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.
- 10 Jun 2011 Actual end date changed from 1 May 2010 to Dec 2010 as reported by ClinicalTrials.gov.
- 03 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.